Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
- Conditions
- Localized Unresectable NeuroblastomaGanglioneuroblastomaStage 4S NeuroblastomaRegional NeuroblastomaLocalized Resectable NeuroblastomaStage 4 Neuroblastoma
- Interventions
- Other: Cytology Specimen Collection ProcedureOther: Laboratory Biomarker Analysis
- First Posted Date
- 2009-05-19
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 10000
- Registration Number
- NCT00904241
- Locations
- 🇺🇸
Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸USA Health Strada Patient Care Center, Mobile, Alabama, United States
Study of DNA in Blood Samples From Patients With Neuroblastoma
- Conditions
- Localized Unresectable NeuroblastomaRegional NeuroblastomaDisseminated NeuroblastomaLocalized Resectable NeuroblastomaRecurrent NeuroblastomaStage 4S Neuroblastoma
- Interventions
- Other: laboratory biomarker analysisGenetic: polymerase chain reactionGenetic: polyacrylamide gel electrophoresisGenetic: DNA analysis
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 329
- Registration Number
- NCT00898391
- Locations
- 🇺🇸
Children's Oncology Group, Monrovia, California, United States
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
- Conditions
- Osteosarcoma
- Interventions
- Other: Cytology Specimen Collection Procedure
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 957
- Registration Number
- NCT00899275
- Locations
- 🇺🇸
Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸Phoenix Childrens Hospital, Phoenix, Arizona, United States
Study of Kidney Tumors in Younger Patients
- Conditions
- Diffuse Hyperplastic Perilobar NephroblastomatosisKidney Wilms TumorRenal Cell CarcinomaCellular Congenital Mesoblastic NephromaClassic Congenital Mesoblastic NephromaKidney OncocytomaMetanephric AdenofibromaMetanephric AdenomaMixed Congenital Mesoblastic NephromaOssifying Renal Tumor of Infancy
- Interventions
- Other: Cytology Specimen Collection ProcedureOther: Laboratory Biomarker Analysis
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 8000
- Registration Number
- NCT00898365
- Locations
- 🇺🇸
Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸USA Health Strada Patient Care Center, Mobile, Alabama, United States
Collecting and Storing Tissue From Young Patients With Cancer
- Conditions
- Ewing SarcomaRetinoblastomaCentral Nervous System NeoplasmGerm Cell TumorLeukemiaLymphomaRhabdoid TumorRhabdomyosarcomaAcute Lymphoblastic LeukemiaMalignant Neoplasm
- Interventions
- Other: Cytology Specimen Collection ProcedureOther: Laboratory Biomarker Analysis
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 213
- Registration Number
- NCT00898755
- Locations
- 🇺🇸
Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸Arkansas Children's Hospital, Little Rock, Arkansas, United States
Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission
- Conditions
- Leukemia
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2015-09-30
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 135
- Registration Number
- NCT00899899
DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia
- Conditions
- Recurrent Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia in Remission
- Interventions
- Other: Laboratory Biomarker Analysis
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2022-08-15
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 520
- Registration Number
- NCT00897507
- Locations
- 🇺🇸
Childrens Oncology Group, Philadelphia, Pennsylvania, United States
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
- Conditions
- Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorAskin TumorMetastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
- Interventions
- Other: Laboratory Biomarker Analysis
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 908
- Registration Number
- NCT00899990
- Locations
- 🇺🇸
Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸Phoenix Childrens Hospital, Phoenix, Arizona, United States
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
- Conditions
- Hairy Cell LeukemiaSecondary Acute Myeloid LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeNeoplasm of Uncertain Malignant PotentialChronic Lymphocytic LeukemiaAcute Undifferentiated LeukemiaChildhood Acute Lymphoblastic LeukemiaChildhood Acute Myeloid LeukemiaChildhood Solid NeoplasmJuvenile Myelomonocytic Leukemia
- Interventions
- Other: Cytology Specimen Collection Procedure
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2018-07-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 2545
- Registration Number
- NCT00898079
- Locations
- 🇺🇸
Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸Phoenix Childrens Hospital, Phoenix, Arizona, United States
Gene Expression Profiles to Categorize Wilms Tumors
- Conditions
- Stage IV Wilms TumorStage I Wilms TumorRecurrent Wilms Tumor and Other Childhood Kidney TumorsStage III Wilms TumorStage V Wilms TumorStage II Wilms Tumor
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 600
- Registration Number
- NCT00897637
- Locations
- 🇺🇸
Children's Oncology Group, Arcadia, California, United States
🇺🇸Saint Mary's Hospital, West Palm Beach, Florida, United States